SmartLabs
SmartLabs provides lab-as-a-service facilities, including R&D labs and vivariums, delivering personalized lab environments in approximately four weeks.
Secondary Market Price
How SmartLabs Measures Up
To help you manage your SmartLabs equity, Prospect has run the company through our machine learning model.
Prospect Rating
--
This rating reflects our belief in this company's potential to grow to that many times its current value in 4 years. For an employee with stock, this rating suggests a potential return on equity, but it also comes with some risk.
Exit Risk
--
Our rating is a reflection of the likelihood of this company achieving a liquidity event for its employees based on the quality of investors, funding stage, founders, and more.
Funding Stage
Series C
A company’s funding stage reflects how established it is, how quickly it is scaling, and the average impact an employee may have when joining.
Secondary Market Price Chart
Create a free account to unlock real-time secondary market prices and future projections of SmartLabs's value.
Sign up to Unlock the Latest DataData will be available soon.
Sign up to receive notifications when it is available.
Prospect Projected Future SmartLabs Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for SmartLabs's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.
Powerful tools to earn more from your equity
Company Description
SmartLabs operates as a lab-as-a-service provider for pharmaceutical and biotechnology organizations. The company delivers personalized lab environments, including R&D suites, vivariums, and manufacturing support, in approximately four weeks, compared to the traditional 9-to-12-month timeline. It also provides comprehensive operational services such as environmental health and safety, facilities management, and IT infrastructure. Founded in 2015 and formerly known as Mass Innovation Labs, the company has raised $357.8 million in total funding and has locations in the Boston area and South San Francisco. Co-founder Seth Taylor serves as the company's Chief Business Officer.
SmartLabs plans to expand into new markets with its Custom Developed Solutions, a service that oversees the design, construction, and operation of new research facilities for clients. The company aims to enhance its members' research capabilities by providing access to new technologies. A recent partnership with Sonrai, for example, gives members access to a multi-omic AI platform for data aggregation and analysis. Other recent activities include CEO Brian Taylor's appearance on a podcast to discuss the company's business model and participation in industry events such as the Biotech Showcase.
- ArrowMark Partners
- Winslow Capital Management
- Conversion Venture Capital
- Onex Falcon
- Breed's Hill Capital
- Co-Founder, Amrit Chaudhuri
- Co-Founder, Seth Taylor
Peer Group Comparison
Vs Peer Group of >$4B Startups
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is SmartLabs worth joining?
Deciding whether to join a company like SmartLabs involves evaluating the total compensation package, including the potential of its equity. Platforms like Prospect can help you analyze the value of your equity offer by using data-driven models to project its future worth.
What should I do with my SmartLabs stock?
The right strategy for your SmartLabs stock depends on your personal financial goals, tax situation, and risk tolerance. Using a service like Prospect can provide a customized, tax-optimized plan for exercising options or selling shares.
Can you sell SmartLabs stock?
As a private company, selling SmartLabs stock is typically only possible during specific liquidity events, such as a tender offer or on a secondary market. Tools like Prospect can help you navigate these opportunities and determine the optimal amount and type of shares to sell for tax purposes.
How can I find the value of my SmartLabs stock?
Determining the value of stock in a private company like SmartLabs can be difficult due to its illiquidity and lack of public market data. Prospect uses machine learning models that analyze funding rounds, secondary market prices, and other data to project the most likely range of outcomes for your equity.
What is SmartLabs's equity worth?
The ultimate worth of your SmartLabs equity depends on the company's future success and your strategy for managing it, including tax implications. Prospect can help you calculate the potential net value of your holdings by providing personalized, tax-optimized strategies and scenario modeling.
What is SmartLabs's stock ticker symbol?
Since SmartLabs is a private, pre-IPO company, it does not have a stock ticker symbol. Ticker symbols are used to identify companies that are traded on public stock exchanges.
Can I buy or sell SmartLabs stock?
For employees, "buying" SmartLabs stock usually means exercising your stock options, while selling is restricted to liquidity events like tender offers or secondary sales. A platform like Prospect offers tools and personalized strategies to guide you through both exercising and selling decisions.
What is the criteria to buy or invest in SmartLabs stock?
Investing in a private company like SmartLabs is typically restricted to employees who receive equity compensation or accredited investors participating in specific funding rounds. Opportunities for the general public to invest are generally not available until a company goes public.
